Subgroups – 6.4 | MedTech, Pharma & Device Innovators – AIiHC ORG

Toggle Side Panel

Home
About Us

Our Story
Community

1. Stakeholder Connect

1.1 Clinician's forum

1.2 Healthcare leaders

1.3 AI Innovators & Developers

1.4 Policy, Regulatory experts

1.5 IT & Infrastructure Management

1.6 Industry & Solution Providers

1.7 Patients & Caregivers

2. AI Adoption cycle

2.1 Exploration and Readiness

2.2 Implementation & Integration

2.3 Monitoring & Optimization

2.4 Future & Emerging AI

3. Ethics & Governances

3.1 Ethical AI & Fairness

3.2 Data Governance & Security

3.3 Regulatory Landscape

3.4 Standards and Best Practices

4. Clinical Domains

4.1 Medical AI

4.2 Surgical AI

4.3 Diagnostic Imaging AI

4.4 Primary Care & Family Medicine

4.5 Medical and Behavioural Health

4.6 Drug Discovery & Pharma

4.7 Public & Population Health

4.8 Hospital System Operations

5. Academics

5.1 Research Project Collaboration

5.2 Grant & Funding Opportunities

5.3 Clinical Trials & Academic Studies

5.4 University & Institution Connect

5.5 Research Methodologies & Tools

5.6 Education & Workforce development

6. Industry Exchange

6.1 AI Application Vendors

6.2 Platform & Infrastructure Providers

6.3 Implementation & Consultancy Partners

6.4 MedTech, Pharma & Device Innovators

6.5 Responsible Industry Practices
Discussions
Contact us

Sign in

Search for:

Home
About Us
Community
Discussions
Contact us

Search for:

6.4 | MedTech, Pharma & Device Innovators

Public Industry Exchange

Public Industry Exchange

Active 3 months ago

Purpose:
To provide a neutral collaboration space for medical device companies, pharma R&D teams,... View more

Public Industry Exchange

Organizer:

Organized by

Group Description

Purpose:
To provide a neutral collaboration space for medical device companies, pharma R&D teams, and digital health innovators who embed AI into hardware or drug development processes.

Description:
Unlike pure software vendors, this group includes companies whose AI is packaged inside medical devices, diagnostics, wearables, or drug discovery platforms.
Their focus is on hardware-AI convergence and AI-driven biomedical innovation.
Examples:
MedTech AI → Siemens Healthineers, Philips, Canon, GE Healthcare (smart imaging devices, AI in scanners).Pharma AI → BenevolentAI, Exscientia, Pfizer (drug discovery & trial optimization).Wearables & Remote Devices → Apple, Fitbit, Withings, AliveCor, Oura (biosensor-driven AI health tracking).

Intended Use:
Share insights on regulatory challenges for AI-embedded devices.Discuss how AI hardware integrates into clinical workflows.Explore AI in drug discovery pipelines (trial design, molecule screening).Exchange lessons on patient adoption of wearables and remote devices.

Limitations:
No promotion of specific devices, drugs, or commercial offerings.No direct-to-patient marketing (especially for wearables).Proprietary R&D pipelines cannot be disclosed — only principles and anonymized lessons.Pharma discussions must remain at process level, not tied to specific products.

Key Activities:
Sharing case lessons (e.g., “Challenges in validating AI-embedded CT scanners in Europe”).Discussing wearable adoption barriers (trust, data privacy, accuracy).Posting trial design frameworks for AI in clinical studies.Hosting cross-industry conversations between pharma, medtech, and clinicians.

Potential Users:
MedTech companies embedding AI in diagnostic & monitoring devices.Pharma companies using AI in R&D and clinical trials.Wearable/device innovators building consumer or clinical-grade devices.Clinicians & hospital leaders evaluating device adoption.Researchers studying AI in drug discovery or biomedical devices.

Possible Discussions:
“How do regulators classify AI-embedded imaging scanners under MDR?”.“What lessons can pharma AI learn from medical device validation?”.“How do you validate AI-driven wearables for chronic disease management?”.“What is the role of AI in optimizing multi-site drug trials?”.“How do patients perceive trustworthiness in wearable health AI?”

Other Important Notes:
This group brings hardware players (medtech, wearables) and drug discovery innovators into AIiHC, broadening beyond imaging AI.It links strongly with Pillar 4 (AI in Clinical & Operational Domains), especially radiology, cardiology, and pathology.It is attractive to cross-industry partnerships (pharma + medtech + AI startups).AIiHC moderators must monitor carefully to prevent product-centric marketing posts.

Leave Group

Are you sure you want to leave ?

Cancel Confirm

Subgroups
Feed
Members
Documents
Discussions

Search anything…

Order By:

Order By:

Loading groups of the community. Please wait.

© 2025 - AI Healthcare Community

Disclaimer
Rules And Regulation
Community Guidelines
Terms of Use
Privacy Policy

Report

There was a problem reporting this post.

Harassment Harassment or bullying behavior

Inappropriate Contains mature or sensitive content

Misinformation Contains misleading or false information

Offensive Contains abusive or derogatory content

Suspicious Contains spam, fake content or potential malware

Other

Report note

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

See blocked member's posts
Mention this member in posts
Invite this member to groups
Message this member
Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .